Searchable abstracts of presentations at key conferences in endocrinology

ea0077p189 | Metabolism, Obesity and Diabetes | SFEBES2021

BMI category-specific waist circumference thresholds for predicting the risk of cardiometabolic diseases: A nationwide population-based study

Son Jang Won , Lee Seong-Su , Kim Sungrae , Kwon Hyuk-Sang , Jib Yoo Soon

Background: There is no existing longitudinal study to support ethnicity-specific and body mass index (BMI) category-specific waist circumference (WC) thresholds and their potential clinical utility to assess the risk of obesity-related diseases.Methods: We performed a prospective assessment of 5,852,702 subjects in large-scale population-based cohort dataset obtained from the Korea National Health Insurance System. BMI was categorized into 6 subgroups (...

ea0081ep395 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The blood lead level is the meaningful indicator to metabolic syndrome in healthy populations

Rae Lee Kyu , Cheol Hwang In , Kon Kim Kyung , Sun Suh Heuy , Dong Ko Ki

Background: Lead is known as an environmental toxic pollutant and hormonal regulatory confounder associated with obesity. Recent China scientific report shows that blood lead level (BLL) is closely related with body mass index. Therefore, we investigated the association between the prevalence of metabolic syndrome and blood lead levels in healthy general population without hypertension, dyslipidemia, and diabetes.Methods: We assessed the socio-demographi...

ea0081ep1156 | Thyroid | ECE2022

Low testosterone: An unexpected journey

Lee Jessica , Casey Edel , Hawkins Anna , Pittathankal Antony , Tanday Raj , Imran Syed , Mlawa Gideon , Nikookam Khash

A 68 year old gentleman referred to endocrinology clinic with a few years history of erectile dysfunction (ED), which manifested as reduced libido and partial erections. Investigations revealed primary hypogonadism with a low morning serum Testosterone of 4.8 (Ref: 7.9-31 nmol/l), raised FSH at 47 (Ref:1.5-12.4 iu/l) LH at 36.8 (Ref: 1.7-8.6iu/l) and normal thyroid function tests (TFTs). The patient declined testosterone replacement therapy following a discussion of pros and c...

ea0085oc5.3 | Oral Communications 5 | BSPED2022

UK protocol for induction of puberty with gonadotropins in males with hypogonadotropic hypogonadism

Dunkel Leo , Prasad Rathi , Martin Lee , Senniappan Senthil , Butler Gary , Howard Sasha

Hypogonadotropic hypogonadism (HH) is a rare reproductive disorder that results in a lack of normal pubertal development and reduced potential for fertility in adult life. The condition is characterised by low circulating sex steroid concentrations resulting from a deficiency of pituitary gonadotropin production. HH may be congenital or acquired, most commonly due to tumour or treatment for malignant disease. When associated with anosmia it is termed Kallmann syndrome. HH is a...

ea0085p15 | Diabetes 1 | BSPED2022

Blindness at initial presentation of new onset diabetes mellitus in a 13 year old girl

Chen Lee Shien , Chizo Agwu Juliana , Kallappa Chetana , Ghauri Abdul-Jabbar

Background: Bilateral cataracts are rarely the initial symptom of diabetes mellitus (DM). Patients with DM who developed cataracts usually have DM for many years. The prevalence of early cataracts in paediatric DM ranges between 0.7 and 3.4%. We report a case of DM diagnosis following onset of blindness due to new bilateral cataracts.Case description: 13-year-old Caucasian girl presented with rapidly declining vision for 2 months. She was blind 2 weeks p...

ea0086oc6.3 | Thyroid | SFEBES2022

Long-Term effectiveness of ethanol ablation in controlling selected postoperative neck nodal metastases in fourteen patients presenting with ATA pediatric intermediate or high-risk papillary thyroid carcinoma

Hay Ian , Lee Robert , Pittock Siobhan , Sharma Animesh , Thompson Geoffrey , Charboneau Bill

Introduction: Childhood papillary thyroid carcinoma (CPTC), despite bilateral thyroidectomy (BT), nodal resection and radioiodine remnant ablation (RRA), recurs within neck nodal metastases (NNM) in >30% within 20 postoperative years. However, these NNM are usually treated with re-operation or further radioiodine; US-guided ethanol ablation (EA) may be considered (j.sempedsurg.2020.150920) for patients with limited numbers of NNMMethods: We studied l...

ea0089c14 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT

Lee Hwan , Patel Vandan , Bhattaru Abhijit , Jean Christopher , Pryma Daniel A , Bravo Paco E

Background: Neuroendocrine tumor (NET) metastases to the heart are found in 1-4% of NET patients and have been reported primarily in the form of individual cases. We investigated the incidence, clinical characteristics, imaging features, and outcomes of NET patients with cardiac metastases on 68Ga-DOTATATE PET/CT.Methods: The medical records of 406 neuroendocrine tumor patients who underwent 68Ga-DOTATATE PET/CT for their clinical c...

ea0090p41 | Calcium and Bone | ECE2023

Vitamin D status and biomarkers of bone health in diabetic adolescents and children in a multi-ethnic cohort

Ho Clement K. M. , Lee Nicole K. L. , Vasanwala Rashida F.

Objectives: This prospective study aimed at investigating (1) the prevalence of vitamin D deficiency and insufficiency in diabetic adolescents and children in a multi-ethnic cohort, and (2) any association between vitamin D status and ethnic background, glycaemic control (HbA1C), biomarkers of metabolic bone health and lipids.Methodology: Venous blood was drawn from 199 patients with type 1 diabetes (mean age ± SD, 8.2 ± 3.7 years) and 48 patients ...

ea0090p366 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Assessing Foundation Doctors knowledge on the use of Sodium-glucose cotransporter 2 (SGLT2) Inhibitors: A Quality Improvement Project

Haddad Aiman , Sharma Angelica , Lee Tse Tsz , Taufik Bara , Seetho Ian

Introduction: Sodium Glucose Co-transporter 2 inhibitors (SGLT2i) are a novel class of glucose-lowering therapies that have demonstrated prognostic benefit in the management diabetes, heart failure and renal impairment. National Institute for Health and Clinical Excellence (NICE) guidance recommends offering SGLT2i, in addition to metformin, first-line in individuals with type 2 diabetes (T2D) and chronic heart failure/ established atherosclerotic cardiovascular disease. Howev...

ea0090p166 | Pituitary and Neuroendocrinology | ECE2023

Doege-Potter Syndrome, a case report

Guerrero Alba , Romero Fabiola , Lopez Helen , Hun Lee Chong , Muller Alejandra , Rodriguez Roque , Valinotti Elizabeth

Introduction: 2 to 3% of the causes of hypoglycemia in the population without diabetes mellitus correspond to tumors of cells other than islets. Below is a rare case of hypoglycemia related to a pleural tumor. Clinical case: A 65-year-old woman with arterial hypertension, psychiatric treatment for confusion and behavioral changes of 6 months of evolution, palpitations and night sweats, loss of 20 kg of weight, several admissions to the emergency room, un...